We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+5.13%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$775M
AUM Growth
-$436M
Cap. Flow
-$471M
Cap. Flow %
-60.72%
Top 10 Hldgs %
18.21%
Holding
4,545
New
711
Increased
1,179
Reduced
1,568
Closed
1,030

Sector Composition

Rank Sector Weight
1 Financials 11.08%
2 Technology 10%
3 Consumer Discretionary 7.02%
4 Healthcare 6.86%
5 Communication Services 6.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NAII icon
2326
Natural Alternatives International
NAII
$14.9M
$14K ﹤0.01%
1,322
-1,038
-44% -$10.8K
NDLS icon
2327
Noodles & Co
NDLS
$107M
$14K ﹤0.01%
+329
New +$12.6K
NHTC icon
2328
Natural Health Trends
NHTC
$14.8M
$14K ﹤0.01%
932
-290
-24% -$5.47K
NNI icon
2329
Nelnet
NNI
$4.72B
$14K ﹤0.01%
250
-2,033
-89% -$110K
NTGR icon
2330
NETGEAR
NTGR
$635M
$14K ﹤0.01%
239
-2,974
-93% -$152K
NTRA icon
2331
Natera
NTRA
$46.1B
$14K ﹤0.01%
1,604
-2,552
-61% -$27.6K
ADAM
2332
Adamas Trust
ADAM
$883M
$14K ﹤0.01%
552
-2,080
-79% -$52.2K
PBYI icon
2333
Puma Biotechnology
PBYI
$454M
$14K ﹤0.01%
138
-1,073
-89% -$120K
PK icon
2334
Park Hotels & Resorts
PK
$2.97B
$14K ﹤0.01%
+475
New +$13.6K
QUIK icon
2335
QuickLogic
QUIK
$257M
$14K ﹤0.01%
568
+51
+10% +$1.15K
RSP icon
2336
Invesco S&P 500 Equal Weight ETF
RSP
$99.5B
$14K ﹤0.01%
141
-9
-6% -$883
SGMO
2337
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$14K ﹤0.01%
832
-1,719
-67% -$25.6K
TANH icon
2338
Tantech Holdings
TANH
$6.1M
$14K ﹤0.01%
+1
New +$27K
VSH icon
2339
Vishay Intertechnology
VSH
$5.43B
$14K ﹤0.01%
701
-10,497
-94% -$224K
VUG icon
2340
Vanguard Morningstar Growth ETF
VUG
$231B
$14K ﹤0.01%
+600
New +$13.8K
VYX icon
2341
NCR Voyix
VYX
$1.14B
$14K ﹤0.01%
663
+500
+307% +$10.1K
WOLF icon
2342
Wolfspeed
WOLF
$1.71B
$14K ﹤0.01%
378
-7,189
-95% -$248K
ZYME icon
2343
Zymeworks
ZYME
$1.73B
$14K ﹤0.01%
1,766
+1,566
+783% +$12.9K
LL
2344
DELISTED
LL Flooring Holdings, Inc.
LL
$14K ﹤0.01%
461
-3,209
-87% -$102K
MRNS
2345
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$14K ﹤0.01%
+430
New +$11.6K
ARGO
2346
DELISTED
Argo Group International Holdings, Ltd.
ARGO
$14K ﹤0.01%
259
-3,428
-93% -$184K
STCN
2347
DELISTED
Steel Connect, Inc. Common Stock
STCN
$14K ﹤0.01%
585
+223
+62% +$3.98K
WRI
2348
DELISTED
Weingarten Realty Investors
WRI
$14K ﹤0.01%
421
+81
+24% +$2.62K
CEL
2349
DELISTED
Cellcom Israel, Ltd.
CEL
$14K ﹤0.01%
1,408
+810
+135% +$7.86K
SRCI
2350
DELISTED
SRC Energy Inc
SRCI
$14K ﹤0.01%
1,584
+700
+79% +$6.17K

Similar funds

Tower Research Capital (TRC)'s Q4 2017 Portfolio in Review

As of Q4 2017, Tower Research Capital (TRC) held 4,545 positions worth $775M, down 36% from $1.21B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Tower Research Capital (TRC) withdrew a net $471M in Q4 2017, closing 1,030 positions and reducing 1,568 holdings. Its most notable exit was iShares MSCI EAFE ETF, an estimated $25.9M position sold in full.

By sector, the portfolio is most concentrated in Financials at 11% of assets, up from 6.3% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Tower Research Capital (TRC) opened a new position in Berkshire Hathaway Class B worth $7.94M.

  • Tower Research Capital (TRC)'s largest Q4 2017 buy was Berkshire Hathaway Class B: 40,072 shares worth $7.94M.
  • Tower Research Capital (TRC) added most to Apple in Q4 2017, an estimated $8.74M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $223M.
  • Tower Research Capital (TRC) fully exited iShares MSCI EAFE ETF in Q4 2017, selling an estimated $25.9M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 18% of its $775M portfolio in Q4 2017.
  • Tower Research Capital (TRC) opened 711 new positions and closed 1,030 in Q4 2017.
  • Tower Research Capital (TRC)'s portfolio value fell 36% quarter-over-quarter to $775M.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2017, filed 9 Feb 2018.